Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Breast cancer/carcinoma

Kato M, Kitayama J, Kazama S, Nagawa H. Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Res 2003 5 144-150. [Pg.345]

Hematologic Head and Neck Gynecologic Genitourinary Gastrointestinal Endocrine Carcinoma Breast Cancer Malignancies Cancer Cancer Cancer Cancer Cancer of Unknown... [Pg.4]

Humanized and chimerized MAbs have been developed for the treatment of non-Hodgkin lymphoma, renal cell carcinoma, ovarian carcinoma, breast cancer, melanoma, and neuroblastoma [117,119,120,123,124]. Patients with relapsed or refractory myeloid leukaemias that have been treated with HuM95, did not develop significant HAMA responses [59]. [Pg.222]

Ofner, D., Bier, B., Heinrichs, S., Berghom, M., Dtinser, M., and Hagemann, H. E. 1996. Demonstration of silver-stained nucleolar organizer regions associated proteins (AgNORs) after wet autoclave pretreatment in breast carcinoma. Breast Cancer Res. Treat. 59 165-167. [Pg.334]

Arteaga and co-workers (144) have utilized a human tumor cloning system to evaluate in vitro the effects of elliptinium (5) against 282 tumor lines, in order to determine which human tumors should be clinically treated with 5. The results indicated that phase II trials in patients with renal cell carcinoma, breast cancer, non small-cell lung cancer, and small-cell lung cancer should be pursued. [Pg.308]

Mammary carcinoma Breast cancer cells, including MCF-7 (human), T47D (human), and MDA-MB-231 (human), have estrogen receptor expression profiles that are different [37], These cells are used to study the responses of breast tissues to estrogen or pharmaceuticals. [Pg.703]

S. Ropero, J. A. Menendez, A. Vazquez-Martin, S. Montero, H. Cortes-Funes, and R. Colomer, Trastuzumab plus tamoxifen anti-proUferative and molecular interactions in breast carcinoma. Breast Cancer Res Treat 86(2) 125-137 (2004). [Pg.1030]

Baselga J, Mendelsohn J. The epidermal growth factor receptor as a target for therapy in breast carcinoma. Breast Cancer Res Treat 1994, 1, 127-38. [Pg.161]

Bougnoux P, Chajes V, Lanson M, Hacene K, Body G, Couet C, Le Floch O. (1992) Prognostic significance of tumor phosphatidylcholine stearic acid level in breast carcinoma. Breast Cancer Res Treat 20 185-194. [Pg.266]

It is broadly employed for the treatment of herpes zoster, herpetic-keratitis, herpes genitalis, chronic hepatitis, common cold and influenza. It also finds its usefulness in limg carcinoma, breast cancer, multiple myelomas. It is also recommended as a prophylactic agent in cytomegalovirus infection in renal transplant patients. [Pg.856]

Madjd Z, Parsons T, Watson NF, Spendlove I, Ellis I, Durrant LG. High expression of Lewis y/b antigens is associated with decreased survival in lymph node negative breast carcinomas. Breast Cancer Res 2005 7 ... [Pg.309]


See other pages where Breast cancer/carcinoma is mentioned: [Pg.136]    [Pg.178]    [Pg.325]    [Pg.570]    [Pg.3454]    [Pg.353]    [Pg.338]    [Pg.155]   
See also in sourсe #XX -- [ Pg.362 ]




SEARCH



Breast cancer ductal carcinoma

Breast cancer infiltrating ductal carcinoma

Breast cancer infiltrating lobular carcinoma

Breast cancer lobular carcinoma

Breast cancer medullary carcinoma

Breast cancer mucinous carcinoma

Breast cancer tubular carcinoma

Carcinoma breast

Carcinoma cancer

© 2024 chempedia.info